FILINGS
| EYPT 0001314102 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2022-01-10 | 8-K | 8-K | View Document |
| 2021-12-10 | 8-K | 8-K | View Document |
| 2021-11-19 | 8-K | 8-K | View Document |
| 2021-11-18 | 424B5 | 424B5 | View Document |
| 2021-11-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-11-17 | FWP | FWP | View Document |
| 2021-11-16 | 424B5 | 424B5 | View Document |
| 2021-11-15 | 8-K | 8-K | View Document |
| 2021-11-05 | 10-Q | 10-Q | View Document |
| 2021-11-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-11-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-11-03 | 3 | PRIMARY DOCUMENT | View Document |
| 2021-11-03 | 8-K | 8-K | View Document |
| 2021-11-01 | 8-K | 8-K | View Document |
| 2021-08-17 | 8-K | 8-K | View Document |
| 2021-08-13 | SC 13G | EYEPOINT PHARMACEUTICALS, INC. | View Document |
| 2021-08-11 | EFFECT | View Document | |
| 2021-08-09 | CORRESP | View Document | |
| 2021-08-09 | UPLOAD | View Document | |
| 2021-08-06 | S-3 | S-3 | View Document |
| 2021-08-06 | S-8 | S-8 | View Document |
| 2021-08-06 | 10-Q | 10-Q | View Document |
| 2021-08-04 | 8-K | 8-K | View Document |
| 2021-07-26 | SC 13G | View Document | |
| 2021-06-24 | 8-K | 8-K | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-15 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-15 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-06-02 | 8-K | 8-K | View Document |
| 2021-05-07 | EFFECT | View Document | |
| 2021-05-05 | CORRESP | View Document | |
| 2021-05-05 | S-3/A | S-3/A | View Document |
| 2021-05-05 | 10-Q | 10-Q | View Document |
| 2021-05-05 | 8-K | 8-K | View Document |
| 2021-05-04 | 10-K/A | 10-K/A | View Document |
| 2021-05-03 | NT 10-K | NT 10-K | View Document |
| 2021-05-03 | DEF 14A | DEF 14A | View Document |
| 2021-04-30 | DEFA14A | DEFA14A | View Document |
| 2021-03-12 | 10-K | 10-K | View Document |
| 2021-03-05 | SEC STAFF LETTER | View Document | |
| 2021-03-04 | 8-K | 8-K | View Document |
| 2021-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-03-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-02-18 | UPLOAD | View Document | |
| 2021-02-12 | SC 13G | EYEPOINT PHARMACEUTICALS, INC. | View Document |
| 2021-02-12 | S-3 | S-3 | View Document |
| 2021-02-11 | 5 | FORM 5 SUBMISSION | View Document |
| 2021-02-04 | SEC STAFF LETTER | View Document | |
| 2021-02-03 | 8-K | 8-K | View Document |
| 2021-02-02 | 424B5 | 424B5 | View Document |
| 2021-02-01 | 424B5 | 424B5 | View Document |
| 2021-02-01 | SC 13G/A | View Document | |
| 2021-01-28 | 8-K | 8-K | View Document |
| 2021-01-25 | EFFECT | View Document | |
| 2021-01-22 | SC 13D | View Document | |
| 2021-01-21 | CORRESP | View Document | |
| 2021-01-21 | UPLOAD | View Document | |
| 2021-01-15 | S-3 | S-3 | View Document |
| 2021-01-14 | 3 | View Document | |
| 2021-01-13 | 3 | PRIMARY DOCUMENT | View Document |
| 2021-01-11 | 8-K | 8-K | View Document |
| 2021-01-06 | D | View Document | |
| 2021-01-04 | 8-K | 8-K | View Document |
| 2020-12-18 | 8-K | 8-K | View Document |
| 2020-12-08 | 8-K | 8-K | View Document |
| 2020-12-03 | 8-K | 8-K | View Document |
| 2020-11-10 | SC 13G | View Document | |
| 2020-11-06 | S-8 | S-8 | View Document |
| 2020-11-06 | 10-Q | 10-Q | View Document |
| 2020-11-05 | 8-K | 8-K | View Document |
| 2020-10-16 | DEFA14A | DEFA14A | View Document |
| 2020-10-16 | DEFA14A | DEFA14A | View Document |
| 2020-10-16 | DEF 14A | DEF 14A | View Document |
| 2020-10-08 | 8-K | 8-K | View Document |
| 2020-10-07 | 8-K | 8-K | View Document |
| 2020-10-06 | PRE 14A | PRE 14A | View Document |
| 2020-09-15 | 8-K | 8-K | View Document |
| 2020-09-09 | 4 | PRIMARY DOCUMENT | View Document |
| 2020-08-26 | 4 | PRIMARY DOCUMENT | View Document |
| 2020-08-20 | 8-K | 8-K | View Document |
| 2020-08-12 | 8-K | 8-K | View Document |
| 2020-08-06 | 8-K | 8-K | View Document |
| 2020-08-05 | 424B5 | 424B5 | View Document |
| 2020-08-05 | 8-K | 8-K | View Document |
| 2020-08-05 | 10-Q | 10-Q | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
